[Vismodegib Therapy for Periocular Basal Cell Carcinoma]. (Record no. 26830949)

MARC details
000 -LEADER
fixed length control field 01285 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517135040.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201708s 0 0 ger d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1439-3999
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-0042-121606
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Keserü, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170828
245 00 - TITLE STATEMENT
Title [Vismodegib Therapy for Periocular Basal Cell Carcinoma].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Klinische Monatsblatter fur Augenheilkunde
Date of publication, distribution, etc. Jan 2017
300 ## - PHYSICAL DESCRIPTION
Extent 64-69 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anilides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Basal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Orbital Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Green, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dulz, S
773 0# - HOST ITEM ENTRY
Title Klinische Monatsblatter fur Augenheilkunde
Related parts vol. 234
-- no. 1
-- p. 64-69
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-0042-121606">https://doi.org/10.1055/s-0042-121606</a>
Public note Available from publisher's website

No items available.